r 3
Schedule 1: replaced, on 1 September 2021, by regulation 4 of the Medicines Amendment Regulations (No 2) 2021 (LI 2021/228).
Every reference to a medicine in this schedule applies whether the medicine is synthetic in origin or is from biological or mineral sources.
Unless specific reference is made otherwise, every reference applies also to medicines that are—
preparations and admixtures containing any proportion of any substance listed in this schedule:
salts and esters of any substance listed in this schedule:
preparations or extracts of biological materials listed in this schedule:
salts or oxides of elements listed in this schedule.
Unless specific reference is made otherwise, every reference to a medicine in this schedule applies,—
if the medicine is an injection or eye preparation, to any concentration of that medicine; and
if the medicine is not an injection or eye preparation, only if the concentration of the medicine is greater than 10 milligrams per litre or per kilogram.
Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using the free acid, base, alcohol, or element unless specifically stated otherwise.
Amending or replacing this Part may affect designated prescriber regulations under section 105(1)(q) of the Act.
19-norandrostenedione
2,4-dinitrochlorobenzene
4-aminopyridine
4-chloromethandienone
4-chlorotestosterone
5-aminolevulinic acid
Abacavir
Abatacept
Abciximab
Abemaciclib
Abiraterone
Abrus precatorius; at all strengths
Acamprosate
Acarbose
Acebutolol
Acepromazine
Acetanilides
Acetarsol
Acetazolamide
Acetohexamide
Acetylcarbromal
Acetylcholine; except in medicines containing 1 milligram or less per litre or per kilogram
Acetylcysteine; for injection or inhalation
Acetyldigitoxin
Acetylmethyldimethyloximidophenylhydrazine
Acetylstrophanthidin
Aciclovir; except when specified elsewhere in this schedule
Acipimox
Acitretin
Aclidinium bromide
Acokanthera ouabaio
Acokanthera schimperi
Aconitum spp; except when specified elsewhere in this schedule
Acrivastine
Adalimumab
Adapalene; except in medicines containing 1 milligram or less per millilitre or gram and when supplied by a pharmacist in a pack containing not more than 30 grams for the treatment of comedo, popular, and pustular acne (acne vulgaris) of the face, chest, or back
Adefovir
Adenosine; for injection
Adinazolam
Adiphenine
Adonis vernalis
Adrafinil
Adrenal extract; except for dermal use in medicines containing 0.02% or less of ketosteroids
Adrenaline; in medicines containing more than 1%
Adrenocortical hormones; except adrenal extract for dermal use containing 0.02% or less of ketosteroids
Afamelanotide
Afatinib
Aflibercept
Agalsidase
Agomelatine
Alatrofloxacin
Albendazole
Albumin; except human albumin
Alclofenac
Alclometasone; except when specified elsewhere in this schedule
Alcohol; for injection in medicines containing more than 20%
Alcuronium
Aldesleukin
Aldosterone; except in medicines containing 10 micrograms or less per litre or per kilogram
Alectinib
Alefacept
Alemtuzumab
Alendronic acid
Alfacalcidol
Alfentanil
Alfuzosin
Alglucerase
Alglucosidase
Alirocumab
Aliskiren
Alitretinoin
Alkyl nitrites
Alkyl sulfonals
Allergens
Allopurinol
Allylisopropylacetylurea; at all strengths
Allyloestrenol
Alogliptin
Aloracetam
Alosetron
Alpelisib
Alpha1-proteinase inhibitor
Alphadolone
Alphaxalone
Alprazolam
Alprenolol
Alprostadil
Alseroxylon
Alteplase
Altretamine
Amantadine
Ambenonium
Ambrisentan
Ambucetamide
Ambutonium
Amcinonide
Amethocaine; except when specified elsewhere in this schedule; for ophthalmic use except when used in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board
Amfebutamone
Amfepramone
Amidopyrine
Amifampridine
Amifostine
Amikacin
Amiloride
Aminocaproic acid
Aminoglutethimide
Aminometradine
Aminophenazone; at all strengths
Aminophylline; except when specified elsewhere in this schedule
Aminopterin
Aminorex
Aminosalicylic acid
Amiodarone
Amiphenazole
Amisometradine
Amisulpride
Amitriptyline
Amlodipine
Ammi visnaga
Ammonium bromide
Amobarbital
Amodiaquine
Amorolfine; except when specified elsewhere in this schedule; except in preparations for the treatment of tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board
Amoxapine
Amoxycillin
Amphomycin
Amphotericin
Ampicillin
Amprenavir
Amrinone
Amsacrine
Amygdalin; at all strengths
Amyl nitrite; except when sold to a person who is appropriately authorised under the Health and Safety at Work Act 2015
Amylocaine
Anabolic steroids
Anagrelide
Anakinra
Anastrozole
Ancestim
Anchusa officinalis; at all strengths
Ancrod and its immunoglobulin antidote
Androgenic and anabolic steroidal agents
Androgens
Androisoxazole
Androstanolone
Androstenediol
Androstenedione
Anecortave
Angiotensinamide
Anidulafungin
Aniracetam
Anistreplase
Antazoline; except for ophthalmic use
Antibiotic substances; except when specified elsewhere in this schedule
Antigens
Antihistamines; except when specified elsewhere in this schedule
Antimony; except in medicines containing 1 milligram or less per litre or per kilogram
Antisera; for injection
AOD-9604
Apalutamide
Apixaban
Apocynum spp
Apomorphine; except in medicines containing 1 milligram or less per litre or per kilogram
Apraclonidine
Apremilast
Aprepitant
Apronal
Aprotinin
Arecoline
Aripiprazole
Aristolochia spp; at all strengths
Aristolochic acid; at all strengths
Armodafinil
Arsenic; except in medicines containing 1 milligram or less per litre or per kilogram
Artemether
Artemisia annua extract
Artesunate
Articaine; except when used as a local anaesthetic in practice by a dental therapist or oral health therapist registered with the Dental Council
Asenapine
Asfotase alfa
Asparaginase
Aspirin; except when specified elsewhere in this schedule; for injection; when combined with caffeine, paracetamol, or salicylamide
Astemizole
Asunaprevir
Atamestane
Atazanavir
Atenolol
Atezolizumab
Atomoxetine
Atorvastatin
Atosiban
Atovaquone
Atracurium
Atropa belladonna; except when specified elsewhere in this schedule; except in medicines containing 300 micrograms or less of total solanaceous alkaloids per litre or per kilogram
Atropine; except when specified elsewhere in this schedule; except when used as an antidote in a device designed for self-injection; except in medicines containing 300 micrograms or less per litre or per kilogram
Atropine methonitrate
Auranofin
Aurothiomalate sodium
Avanafil
Avelumab
Avibactam
Aviptadil
Axitinib
Azacitidine
Azacyclonol
Azapropazone
Azaribine
Azatadine; except when specified elsewhere in this schedule
Azathioprine
Azelaic acid; except when specified elsewhere in this schedule
Azelastine; except when specified elsewhere in this schedule
Azithromycin
Azlocillin
Aztreonam
Bacampicillin
Bacitracin
Baclofen
Baloxavir marboxil
Balsalazide
Bambuterol
Bamethan
Bamipine
Bamlanivimab
Barbital
Barbiturates
Baricitinib
Basiliximab
Bazedoxifene
Becaplermin
Beclamide
Beclomethasone; except when specified elsewhere in this schedule
Bedaquiline
Belatacept
Belimumab
Bemegride
Benactyzine
Benazepril
Bendamustine
Bendrofluazide
Benethamine penicillin
Benorylate
Benoxaprofen
Benperidol
Benralizumab
Benserazide
Benzathine penicillin
Benzatropine
Benzbromarone
Benzhexol
Benzilonium
Benzocaine; except when specified elsewhere in this schedule
Benzodiazepine derivatives; except when specified elsewhere in this schedule
Benzodiazepines; except when specified elsewhere in this schedule
Benzoyl metronidazole
Benzoyl peroxide; except when specified elsewhere in this schedule
Benzthiazide
Benzydamine; except when specified elsewhere in this schedule
Benzylpenicillin
Bepridil
Beractant
Besifloxacin
Beta carotene; in medicines containing more than 18 milligrams per recommended daily dose
Betahistine
Betaine; for the treatment of homocystinuria
Betamethasone
Betaxolol
Bethanechol
Bethanidine
Bevacizumab
Bevantolol
Bexarotene
Bezafibrate
Bezlotoxumab
Bicalutamide
Bictegravir
Bifonazole; except when specified elsewhere in this schedule
Bilastine; except when specified elsewhere in this schedule
Bimatoprost
Binimetinib
Biperiden
Bismuth; except for external use in medicines containing 3% or less
Bisoprolol
Bithionol; at all strengths
Bivalirudin
Bleomycin
Blinatumomab
Boceprevir
Bolandiol
Bolasterone
Bolazine
Boldenone
Bolenol
Bolmantalate
Boron, including borax and boric acid; except in medicines for internal use containing 6 milligrams or less per recommended daily dose; except in medicines for dermal use other than paediatric use containing 0.35% or less; except when present as an excipient
Bortezomib
Bosentan
Bosutinib
Botulinum toxins
Brentuximab vedotin
Bretylium
Brexpiprazole
Brigatinib
Brimonidine
Brinzolamide
Brivaracetam (and its stereoisomers)
Brolucizumab
Bromazepam
Bromocriptine
Bromoform
Brompheniramine; except when specified elsewhere in this schedule
Bromvaletone
Brotizolam
Brugmansia spp
Buclizine; except for oral use
Budesonide; except when specified elsewhere in this schedule
Bufexamac; except in suppositories; except for dermal use in medicines containing 5% or less
Bumetanide
Buniodyl sodium; at all strengths
Buphenine
Bupivacaine
Buprenorphine
Bupropion
Buserelin
Buspirone
Busulphan
Butacaine
Butobarbital
Butoconazole; except for vaginal use
Butorphanol
Butyl aminobenzoate; except in medicines for dermal use containing 2% or less
Butyl nitrite
Butylchloral hydrate
Cabazitaxel
Cabergoline
Cabotegravir
Cabozantinib
Cacalia spp; at all strengths
Cadmium
Calcipotriol; except in medicines containing not more than 50 micrograms per gram or per millilitre and when sold in a pack of not more than 30 grams or 30 millilitres by a pharmacist to an adult with mild to moderate psoriasis previously diagnosed by a doctor
Calcitonin
Calcitriol
Calcium carbimide
Calcium polystyrene sulphonate
Calotropis gigantea
Calotropis procera
Calusterone
Camazepam
Camphorated oil
Camphotamide
Canagliflozin
Canakinumab
Candesartan
Candicidin
Cannabidiol
Capecitabine
Capreomycin
Captodiame
Captopril
Capuride
Caramiphen
Carbachol
Carbamazepine
Carbaryl; except for external use in medicines containing 2% or less
Carbazochrome
Carbenicillin
Carbenoxolone; except for external use
Carbetocin
Carbidopa
Carbimazole
Carbocromen
Carboplatin
Carboprost
Carbromal
Carbutamide
Carbuterol
Carfilzomib
Carglumic acid
Carindacillin
Carisoprodol
Carmustine
Carprofen
Carvedilol
Caspofungin
Catumaxomab
Cebaracetam (and its stereoisomers)
Cedazuridine
Cefacetrile
Cefaclor
Cefaloridine
Cefamandole
Cefapirin
Cefazolin
Cefepime
Cefetamet
Cefixime
Cefodizime
Cefonicid
Cefoperazone
Cefotaxime
Cefotetan
Cefotiam
Cefoxitin
Cefpirome
Cefpodoxime
Cefsulodin
Ceftaroline fosamil
Ceftazidime
Ceftibuten
Ceftolozane
Ceftriaxone
Cefuroxime
Celecoxib
Celiprolol
Cenegermin
Cephaelis acuminata; except in medicines containing less than 0.2% of emetine
Cephaelis ipecacuanha; except in medicines containing less than 0.2% of emetine
Cephalexin
Cephalothin
Cephradine
Ceritinib
Cerivastatin
Cerliponase alfa
Certolizumab pegol
Ceruletide
Cetirizine; except when specified elsewhere in this schedule
Cetrorelix
Cetuximab
Chenodeoxycholic acid
Chloral hydrate; except for dermal use in medicines containing 2% or less
Chloralformamide
Chloralose
Chlorambucil
Chloramphenicol; except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board; except when specified elsewhere in this schedule
Chlorandrostenolone
Chlorazanil
Chlorcyclizine
Chlordiazepoxide
Chlormerodrin
Chlormethiazole
Chlormezanone
Chloroform; for anaesthesia; except when specified elsewhere in this schedule
Chloroquine
Chlorothiazide
Chlorotrianisene
Chloroxydienone
Chloroxymesterone
Chlorpheniramine; except when specified elsewhere in this schedule
Chlorphentermine
Chlorpromazine
Chlorpropamide
Chlorprothixene
Chlorquinaldol
Chlortetracycline
Chlorthalidone
Chlorzoxazone
Cholera vaccine; except in the form of an oral liquid containing vibrio cholerae when sold in a pharmacy by a registered pharmacist
Cholic acid
Choline salicylate; except in medicines containing 10% or less and in pack sizes of 15 grams or less
Chorionic gonadotrophin; except in pregnancy test kits
Chymopapain
Ciclacillin
Ciclesonide
Ciclopirox; except when specified elsewhere in this schedule
Cidofovir
Cilastatin
Cilazapril
Cilnidipine
Cilostazol
Cimetidine; except when specified elsewhere in this schedule
Cinacalcet
Cinchocaine; for injection; for ophthalmic use; for external use in medicines containing more than 0.5%
Cinchophen
Cinnarizine
Cinoxacin
Ciprofloxacin
Cisapride
Cisatracurium
Cisplatin
Citalopram
CJC-1295
Cladribine
Clarithromycin
Clavulanic acid
Clemastine; except for oral use
Clemizole
Clenbuterol
Clevidipine
Clidinium
Clindamycin
Clioquinol; at all strengths
Clobazam
Clobetasol
Clobetasone; except when specified elsewhere in this schedule
Clocortolone
Clodronic acid
Clofarabine
Clofazimine
Clofenamide
Clofibrate
Clomiphene
Clomipramine
Clomocycline
Clonazepam
Clonidine
Clopamide
Clopidogrel
Clorazepic acid
Clorexolone
Clorprenaline
Clostebol
Clotiazepam
Clotrimazole; except when specified elsewhere in this schedule
Cloxacillin
Cloxazolam
Clozapine
Cobalt
Cobicistat
Cobimetinib
Cocaine; except when specified elsewhere in this schedule
Codeine
Co-dergocrine
Colaspase
Colchicine
Colchicum
Colecalciferol; except in medicines containing 25 micrograms or less per recommended daily dose; except in parenteral nutrition replacement preparations
Colestipol
Colestyramine
Colfosceril
Colistin
Collagen; in injections or implants for tissue augmentation or cosmetic use
Collagenase clostridium histolyticum
Coluracetam
Conium maculatum; at all strengths
Convallaria keiski
Convallaria majalis
Corifollitropin alfa
Coronilla spp
Corticosterone
Corticotrophin
Cortisone and other steroidal hormones of the adrenal cortex; except when specified elsewhere in this schedule; except adrenal extract for dermal use in medicines containing 0.02% or less of ketosteroids
Cotarnine; at all strengths
Co-trimoxazole
Coumarin
COVID-19 vaccines; except when administered by vaccinators, registered pharmacists, or registered intern pharmacists who have successfully completed the COVID-19 Vaccinator Education Course (or any equivalent training course on COVID-19 vaccination approved by the Ministry of Health) and who comply with the immunisation standards of the Ministry of Health (but excluding vaccinators who have completed the Provisional Vaccinator Foundation Course or the COVID-19 Vaccinator - Working under Supervision Course)
Crisaborole
Crizotinib
Crofelemer
Crotalaria spp; at all strengths
Croton tiglium; except in medicines containing 1 milligram or less per litre or per kilogram
Crystal violet
Curare
Cyclandelate
Cyclizine; except when specified elsewhere in this schedule
Cyclobenzaprine
Cyclofenil
Cycloheximide
Cyclopenthiazide
Cyclopentolate; except when used in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board
Cyclophosphamide
Cyclopropane
Cycloserine
Cyclosporin
Cyclothiazide
Cycrimine
Cymarin
Cynoglossum spp; at all strengths
Cyproheptadine; except for oral use
Cyproterone
Cysteamine
Cytarabine
Dabigatran
Dabrafenib mesilate
Dacarbazine
Daclatasvir
Daclizumab
Dactinomycin
Dalfopristin
Dalteparin
Danaparoid
Danazol
Danthron
Dantrolene
Dapagliflozin
Dapoxetine
Dapsone
Daptomycin
Daratumumab
Darbepoetin
Darifenacin
Darolutamide
Darunavir
Dasabuvir
Dasatinib
Datura spp; except for oral use when specified elsewhere in this schedule; except datura stramonium or datura tatula for smoking or burning
Daunorubicin
Deanol
Debrisoquine
Decamethonium
Decitabine
Deferasirox
Deferiprone
Defibrotide
Deflazacort
Degarelix
Dehydrochloromethyltestosterone
Dehydrocorticosterone
Delavirdine
Delorazepam
Demecarium
Demeclocycline
Denosumab
Deoxycortone
Deoxycholic acid; for injection; except for oral use
Deoxyribonuclease; except for external use
Dermatophagoides farina allergen extract
Dermatophagoides pteronyssinus allergen extract
Desferrioxamine
Desflurane
Desipramine
Desirudin
Deslanoside
Desloratadine; except for oral use
Deslorelin
Desmopressin
Desogestrel; except when supplied for oral contraception to women who meet the clinical and eligbility criteria of the Pharmacy Council and the Pharmaceutical Society of New Zealand Incorporated approved training programme on oral contraception, when sold in the manufacturer’s original pack that has received the consent of the Minister or Director-General to their distribution as medicines, containing not more than 6 months’ supply by a registered pharmacist who has successfully completed the approved training programme
Desonide
Desoximetasone
Desvenlafaxine
Dexamethasone
Dexamfetamine
Dexchlorpheniramine; except when specified elsewhere in this schedule
Dexfenfluramine
Dexmedetomidine
Dextromethorphan; except when specified elsewhere in this schedule
Dextromoramide
Dextropropoxyphene
Dextrorphan
Di-iodohydroxy quinoline; except when specified elsewhere in this schedule
Di-isopropylamine dichloroacetate
Diazepam
Diazoxide
Dibenzepin
Dibotermin
Dibrompropamidine; except for ophthalmic use
Dichloralphenazone
Dichlorophen
Dichlorphenamide
Diclofenac; in preparations for the treatment of solar keratosis; except when specified elsewhere in this schedule; except in preparations for topical use other than for the treatment of solar keratosis
Dicloxacillin
Dicyclomine
Didanosine
Dienoestrol
Dienogest
Diethazine
Diethylcarbamazine
Diethylstilbestrol
Diflorasone
Diflucortolone
Diflunisal
Digitalis lanata
Digitalis purpurea
Digitoxin
Digoxin
Digoxin-specific antibody fragment
Dihydralazine
Dihydrocodeine
Dihydroergotoxine
Dihydrolone
Dihydrotachysterol
Diltiazem
Dimenhydrinate; except when specified elsewhere in this schedule
Dimercaprol
Dimethandrostanolone
Dimethazine
Dimethindene; except for oral use
Dimethothiazine
Dimethoxanate
Dimethyl fumarate
Dimethyl sulphoxide
Dimiracetam (and its stereoisomers)
Dinitrocresols
Dinitronaphthols
Dinitrophenols
Dinitrothymols
Dinoprost
Dinoprostone
Diperodon
Diphemanil; except for dermal use
Diphenhydramine; except when specified elsewhere in this schedule
Diphenidol
Diphenoxylate; except when specified elsewhere in this schedule
Diphenylpyraline
Diphtheria, tetanus, and pertussis (acellular, component) vaccine; except when administered in a single dose to a person 18 years of age or over or to a pregnant woman aged 13 years or over by a registered pharmacist who has successfully completed the Vaccinator Foundation Course (or any equivalent training course approved by the Ministry of Health) and who complies with the immunisation standards of the Ministry of Health (but excluding a vaccinator who has completed the Provisional Vaccinator Foundation Course)
Diphtheria toxoid
Diphtheria vaccine
Dipivefrin
Dipyridamole
Dirithromycin
Disopyramide
Distigmine
Disulfiram
Disulphamide
Ditiocarb
DMHA, including the isomers 2-amino-6-methylheptane (also known as 1,5-dimethylhexylamine, and octodrine) and 2-amino-5-methylheptane (also known as 1,4-dimethylhexylamine)
Dobutamine
Docetaxel
Dofetilide
Dolasetron
Doliracetam (and its stereoisomers)
Dolutegravir
Domperidone
Donepezil
Dopamine
Dopexamine
Doravirine
Doripenem
Dornase
Dorzolamide
Dothiepin
Doxantrazole
Doxapram
Doxazosin
Doxepin
Doxorubicin
Doxycycline
Doxylamine; except when specified elsewhere in this schedule
Dronedarone
Droperidol
Drospirenone
Drostanolone
Drotrecogin
Duboisia leichhardtii; except when specified elsewhere in this schedule
Duboisia myoporides; except when specified elsewhere in this schedule
Dulaglutide
Dulcin; at all strengths
Duloxetine
Dupilumab
Dupracetam
Durvalumab
Dutasteride
Dydrogesterone
Econazole; except when specified elsewhere in this schedule
Ecothiopate
Ectylurea
Eculizumab
Edetic acid; except in medicines containing 0.25% or less; except in contact lens preparations; except dicobalt edetate for the treatment of cyanide poisoning
Edoxudine
Edrophonium
Efalizumab
Efavirenz
Eflornithine
Elbasvir
Eletriptan
Elosulfase alfa
Elotuzumab
Eltrombopag olamine
Eluxadoline
Elvitegravir
Emepronium
Emetine; except in medicines containing 0.2% or less
Emicizumab
Empagliflozin
Emtricitabine
Enalapril
Enasidenib
Encorafenib
Enestebol
Enflurane
Enfuvirtide
Enobosarm
Enoxacin
Enoxaparin
Enoximone
Enprostil
Entacapone
Entecavir
Entrectinib
Enzalutamide
Ephedrine
Epicillin
Epinastine
Epirubicin
Epitiostanol
Eplerenone
Epoetins
Epoprostenol
Eprosartan
Eptifibatide
Erenumab
Ergocalciferol; except in medicines containing 25 micrograms or less per recommended daily dose
Ergometrine
Ergot
Ergotamine
Ergotoxine
Eribulin
Erlotinib
Ertapenem
Ertugliflozin
Erysimum spp; except in medicines containing 1 milligram or less per litre or per kilogram
Erythromycin
Erythropoietin
Escitalopram
Esketamine
Esmolol
Esomeprazole; except when specified elsewhere in this schedule
Estazolam
Estramustine
Estropipate
Etanercept
Ethacrynic acid
Ethambutol
Ethamivan
Ethanolamine; for injection
Ethchlorvynol
Ether; for anaesthesia; except when specified elsewhere in this schedule
Ethinamate
Ethinyloestradiol; except when supplied at a strength of 35 micrograms or less in combination with either levonorgestrel or norethisterone for oral contraception to women who meet the clinical and eligibility criteria of the Pharmacy Council and the Pharmaceutical Society of New Zealand Incorporated approved training programme on oral contraception, when sold in the manufacturer’s original pack that has received the consent of the Minister or Director-General to their distribution as medicines, containing not more than 6 months’ supply by a registered pharmacist who has successfully completed the approved training programme
Ethionamide
Ethisterone
Ethoglucid
Ethoheptazine
Ethopropazine
Ethosuximide
Ethotoin
Ethoxzolamide
Ethyl chloride; for inhalation
Ethyl loflazepate
Ethyldienolone
Ethylhexanediol; at all strengths
Ethyloestrenol
Ethynodiol
Etidocaine
Etidronic acid; except in medicines for external use containing 1% or less
Etilefrine
Etiracetam
Etodolac
Etofenamate; except for external use
Etomidate
Etonogestrel
Etoposide
Etoricoxib
Etravirine
Etretinate
Everolimus
Evolocumab
Exemestane
Exenatide
Ezetimibe
Factor VIII inhibitor bypassing fraction
Famciclovir; except when specified elsewhere in this schedule
Famotidine; except when specified elsewhere in this schedule
Fampridine
Farfugium japonicum; at all strengths
Fasoracetam (and its stereoisomers)
Febuxostat
Felbamate
Felbinac; except for external use
Felodipine
Felypressin; except when combined with a local anaesthetic and used in practice by a dental therapist or oral health therapist registered with the Dental Council
Fenbufen
Fenclofenac
Fenfluramine
Fenofibrate
Fenoldopam
Fenoprofen
Fenoterol
Fenpipramide
Fenpiprane
Fentanyl
Ferric carboxymaltose
Ferric derisomaltose
Fexofenadine; except when specified elsewhere in this schedule
Fibrin
Fibrinolysin; except for external use
Fibroblast growth factor
Fidaxomicin
Filgrastim
Finasteride
Fingolimod
Flecainide
Fleroxacin
Floctafenine
Fluanisone
Flubromazolam
Fluclorolone
Flucloxacillin
Fluconazole; except when specified elsewhere in this schedule
Flucytosine
Fludarabine
Fludiazepam
Fludrocortisone
Flufenamic acid
Flumazenil
Flumethasone
Flumethiazide
Flunarizine
Flunisolide
Flunitrazepam
Fluocinolone
Fluocinonide
Fluocortin
Fluocortolone
Fluorescein; for injection
Fluorides; for internal use in medicines containing more than 0.5 milligrams per dose unit except in medicines containing 15 milligrams or less per litre or per kilogram; except in parenteral nutrition replacement preparations; for external use in medicines containing more than 5.5 grams per litre or per kilogram except when supplied to a dental professional registered with the Dental Council
Fluorometholone
Fluorouracil
Fluoxetine
Fluoxymesterone
Flupenthixol
Fluphenazine
Flurandrenolone
Flurazepam
Flurbiprofen; except when specified elsewhere in this schedule
Fluroxene
Fluspirilene
Flutamide
Fluticasone; except when specified elsewhere in this schedule
Fluvastatin
Fluvoxamine
Folic acid; except when specified elsewhere in this schedule
Folinic acid; except when specified elsewhere in this schedule
Follicle-stimulating hormone; except in medicines containing 100 micrograms or less per litre or per kilogram
Follistatin
Follitropin
Follitropin delta
Fomepizole
Fomivirsen
Fondaparinux
Fonturacetam (and its stereoisomers)
Formebolone
Formestane
Formoterol
Fosamprenavir
Fosaprepitant
Foscarnet
Fosfestrol
Fosfomycin
Fosinopril
Fosnetupitant
Fosphenytoin
Fotemustine
Framycetin
Fremanezumab
Fulvestrant
Furaltadone
Furazabol
Furazolidone
Furosemide
Fusidic acid
Gabapentin
Galantamine
Galanthus spp
Galcanezumab
Gallamine
Galsulfase
Ganciclovir
Ganirelix
Gatifloxacin
Gefitinib
Gemcitabine
Gemeprost
Gemfibrozil
Gemifloxacin
Gemtuzumab ozogamicin
Gentamicin
Gestodene
Gestonorone
Gestrinone
Ghrelin
Gilteritinib
Gitalin
Glatiramer acetate
Glecaprevir
Glibenclamide
Glibornuride
Gliclazide
Glimepiride
Glipizide
Glisoxepide
Glutathione; for injection
Glyceryl trinitrate; for injection; for transdermal use; except in medicines containing 100 micrograms or less per litre or per kilogram
Glycopyrronium
Glymidine
Golimumab
Gonadorelin
Gonadotrophic hormones; except when specified elsewhere in this schedule
Goserelin
Gramicidin
Granisetron
Grazoprevir
Grepafloxacin
Griseofulvin
Growth hormone releasing hormones
Growth hormone releasing peptide-6
Growth hormone releasing peptides
Guaifenesin; except when specified elsewhere in this schedule
Guanabenz
Guanethidine
Guanfacine
Guanidine
Guselkumab
Hachimycin
Haematin
Haemophilus influenzae vaccine; except in oral vaccines for the prophylaxis of bacterial complications of colds
Halazepam
Halcinonide
Halofantrine
Halofenate
Haloperidol; except in medicines containing 1 milligram or less per litre or per kilogram
Halothane
Haloxazolam
Halquinol; except for external use
Heliotropium spp; at all strengths
Hemerocallis
Heparins; except when present as an excipient; except for external use
Hepatitis A vaccine
Hepatitis B vaccine
Hetacillin
Hexachlorophane; in medicines containing more than 3%; except when specified elsewhere in this schedule
Hexamethonium
Hexarelin
Hexetidine; except for external use
Hexobendine
Hexocyclium
Hexoprenaline
Hexaminolevulinate
Histamine; except in medicines containing 0.5% or less
Homatropine
Human chorionic gonadotrophin; except in pregnancy test kits
Human growth hormone secretagogues
Human papillomavirus vaccine; except when administered by a registered pharmacist or registered intern pharmacist who has successfully completed the Vaccinator Foundation Course (or any equivalent training course approved by the Ministry of Health) and who complies with the immunisation standards of the Ministry of Health (but excluding a vaccinator who has completed the Provisional Vaccinator Foundation Course)
Human protein C
Hyaluronic acid; in injections or implants for tissue augmentation or cosmetic use
Hydralazine
Hydrargaphen
Hydrochlorothiazide
Hydrocortisone; except when specified elsewhere in this schedule
Hydrocyanic acid; except when specified elsewhere in this schedule
Hydroflumethiazide
Hydromorphone
Hydroquinone; except when specified elsewhere in this schedule
Hydroxychloroquine
Hydroxyephedrine
Hydroxyphenamate
Hydroxyprogesterone
Hydroxystenozol
Hydroxyurea
Hydroxyzine
Hylan polymer; in injections or implants for tissue augmentation or cosmetic use
Hyoscine; except when specified elsewhere in this schedule; except in medicines containing 300 micrograms or less per litre or per kilogram
Hyoscine butylbromide; except when specified elsewhere in this schedule
Hyoscyamine; except when specified elsewhere in this schedule; except in medicines containing 300 micrograms or less per litre or per kilogram
Hyoscyamus niger; except when specified elsewhere in this schedule
Hypothalamic releasing factors
Hypromellose; for injection; except in intraocular viscoelastic products
Ibandronic acid
Ibogaine
Ibritumomab tiuxetan
Ibrutinib
Ibufenac
Ibuprofen; except when specified elsewhere in this schedule
Ibutamoren
Ibuterol
Ibutilide
Icatibant
Idarubicin
Idarucizumab
Idebenone
Idelalisib
Idoxuridine; except for dermal use in medicines containing 0.5% or less
Idursulfase
Ifosfamide
Iloprost
Imatinib
Imiglucerase
Imipenem
Imipramine
Imiquimod
Immunoglobulins
Imuracetam
Indacaterol
Indapamide
Indinavir
Indocyanine green
Indomethacin; except when specified elsewhere in this schedule
Indoprofen
Indoramin
Infliximab
Influenza and coryza vaccines; for injection; for nasal use
Influenza vaccine; except when administered by vaccinators, registered pharmacists, or registered intern pharmacists who have successfully completed the Vaccinator Foundation Course (or any equivalent training course approved by the Ministry of Health) and who comply with the immunisation standards of the Ministry of Health (but excluding vaccinators who have completed the Provisional Vaccinator Foundation Course)
Ingenol mebutate
Inotuzumab ozogamicin
Insulin degludec
Insulin-like growth factors; except when specified elsewhere in this schedule
Insulins
Interferons
Interleukins
Iodothiouracil
Ipamorelin
Ipecacuanha; except when specified elsewhere in this schedule
Ipilimumab
Ipratropium; except for nasal use
Ipriflavone
Iprindole
Iproniazid
Irbesartan
Irinotecan
Iron; except when specified elsewhere in this schedule
Isatuximab
Isavuconazole
Isoaminile
Isoamyl nitrite
Isobutyl nitrite
Isocarboxazid
Isoconazole; except when specified elsewhere in this schedule
Isoetarine
Isoflurane
Isometheptene
Isoniazid
Isoprenaline
Isoprinosine
Isopropamide; except when specified elsewhere in this schedule
Isosorbide dinitrate
Isosorbide mononitrate
Isotretinoin
Isoxicam
Isoxsuprine
Isradipine
Itraconazole
Ivabradine
Ivacaftor
Ivermectin
Ixabepilone
Ixazomib
Ixekizumab
Japanese encephalitis vaccine
Juniperus sabina; at all strengths
Kanamycin
Ketamine
Ketanserin
Ketazolam
Ketoconazole; except when specified elsewhere in this schedule
Ketoprofen; except when specified elsewhere in this schedule
Ketorolac
Ketotifen; except for ophthalmic use in medicines containing 0.025% or less
Khellin
Labetalol
Lacidipine
Lacosamide
Lamivudine
Lamotrigine
Lanadelumab
Lanatosides
Lanreotide
Lansoprazole; except when specified elsewhere in this schedule
Lanthanum
Lapatinib
Laronidase-rch
Laropiprant
Larotrectinib
Latamoxef
Latanoprost
Laudexium
Lauromacrogols; for injection
Lead
Ledipasvir
Lefetamine
Leflunomide
Lenalidomide
Lenograstim
Lenvatinib
Lepirudin
Leptazol
Lercanidipine
Lesinurad
Letermovir
Letrozole
Leucovorin; for injection
Leuprorelin
Levallorphan
Levamisole
Levetiracetam
Levobunolol
Levobupivacaine
Levocabastine; except for nasal or ophthalmic use
Levocetirizine; except for oral use
Levodopa
Levomepromazine
Levomilnacipran
Levonorgestrel; except when specified elsewhere in this schedule; except in medicines for use as emergency post-coital contraception when sold by nurses recognised by their professional body as having competency in the field of sexual and reproductive health; except when sold by nurses recognised by their professional body as having competency in the field of sexual and reproductive health; except when supplied for oral contraception to women who meet the clinical and eligibility criteria of the Pharmacy Council and the Pharmaceutical Society of New Zealand Incorporated approved training programme on oral contraception, when sold in the manufacturer’s original pack that has received the consent of the Minister or Director-General to their distribution as medicines, containing not more than 6 months’ supply by a registered pharmacist who has successfully completed the approved training programme
Levosimendan
Lidoflazine
Lidocaine; for injection except when used as a local anaesthetic in practice by a nurse whose scope of practice permits the performance of general nursing functions or by a podiatrist registered with the Podiatrists Board or by a dental therapist or an oral health therapist registered with the Dental Council; for ophthalmic use except when used in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board; for oral use except in throat lozenges containing 30 milligrams or less per dose form; for external use in medicines containing more than 10%; except in throat sprays in medicines containing 2% or less; except when specified elsewhere in this schedule
Lifitegrast
Ligularia dentata; at all strengths
Linaclotide
Linagliptin
Lincomycin
Lindane; except for external use in medicines containing 2% or less
Linezolid
Liothyronine
Lipegfilgrastim
Liraglutide
Lisdexamfetamine
Lisinopril
Lisuride
Lithium; except when specified elsewhere in this schedule; except when present as an excipient in dermal medicines containing 0.25% or less
Lixisenatide
Lodoxamide; except in medicines for ophthalmic use
Lofexidine
Lomefloxacin
Lomustine
Loperamide; except when specified elsewhere in this schedule
Lopinavir
Loprazolam
Loracarbef
Loratadine; except when specified elsewhere in this schedule
Lorazepam
Lorlatinib
Lormetazepam
Losartan
Loteprednol
Lovastatin; except when present as an unmodified, naturally occurring substance in a food that has not been subject to a manufacturing process other than heating, freezing, drying, preserving, bottling, canning, or packaging in retort pouches
Loxapine
Lumacaftor
Lumefantrine
Lumiracoxib
Lurasidone
Luteinising hormone
Lymecycline
Macitentan
Mafenide
Mannomustine
Maprotiline
Maraviroc
Mazindol
Measles vaccine; except when administered, in combination with mumps and rubella vaccines in a combination product the supply of which the Minister of Health has consented to, by vaccinators, registered pharmacists, or registered intern pharmacists who have successfully completed the Vaccinator Foundation Course (or any equivalent training course approved by the Ministry of Health) and who comply with the immunisation standards of the Ministry of Health (but excluding vaccinators who have completed the Provisional Vaccinator Foundation Course)
Mebanazine
Mebeverine
Mebhydrolin
Mebolazine
Mebutamate
Mecamylamine
Mecasermin
Mecillinam
Meclocycline
Meclofenamate
Meclofenoxate
Meclozine; except when specified elsewhere in this schedule
Medazepam
Medigoxin
Medroxyprogesterone
Medrysone
Mefenamic acid; except when specified elsewhere in this schedule
Mefloquine
Mefruside
Megestrol
Melagatran
Melanocyte stimulating compounds
Melatonin; except when supplied in medicines for oral use containing 3 milligrams or less per immediate release dose unit, or 2 milligrams or less per modified release dose unit, when sold in the manufacturer’s original pack that has received consent from the Minister of Health or the Director General for the treatment of primary insomnia for adults aged 55 years or older for up to 13 weeks by a registered pharmacist
Meldonium
Melengestrol
Melia azedarach; at all strengths
Meloxicam
Melphalan
Memantine
Meningococcal vaccine; except when administered to a person 16 years of age or over by a registered pharmacist who has successfully completed the Vaccinator Foundation Course (or any equivalent training course approved by the Ministry of Health) and who complies with the immunisation standards of the Ministry of Health (but excluding a vaccinator who has completed the Provisional Vaccinator Foundation Course)
Menotrophin
Mepacrine
Mepenzolate
Mephenesin
Mephentermine
Mepindolol
Mepitiostane
Mepivacaine
Mepolizumab
Meprobamate
Meptazinol
Mepyramine; except when specified elsewhere in this schedule
Mequitazine
Mercaptomerin
Mercaptopurine
Mercurochrome; except when specified elsewhere in this schedule
Mercury; except when specified elsewhere in this schedule
Meropenem
Mersalyl
Mesabolone
Mesalazine
Mesna
Mestanolone
Mesterolone
Mestranol
Metamfetamine
Metamizole
Metandienone
Metaraminol
Metenolone
Metergoline
Metformin
Methacholine
Methacycline
Methadone
Methallenoestril
Methandriol
Methanthelinium
Methazolamide
Methdilazine; except for oral use
Methicillin
Methimazole
Methisazone
Methixene
Methocarbamol
Methohexitone
Methoin
Methotrexate
Methoxamine; except when specified elsewhere in this schedule
Methoxsalen
Methoxyflurane
Methsuximide
Methyclothiazide
Methyl aminolevulinate
Methyl androstanolone
Methyl clostebol
Methyl mercury; except in medicines containing 300 micrograms or less per litre or per kilogram
Methyl salicylate; except for external use; except for internal use when present as an excipient in medicines containing 1.04% or less per dose form
Methyl trienolone
Methyldopa
Methylene blue; for injection
Methylergometrine
Methylhexanamine (1,3-dimethylamylamine (DMAA)); except when present as an unmodified, naturally occurring substance
Methylnaltrexone
Methylpentynol
Methylphenidate
Methylphenobarbital
Methylphenylpiracetam
Methylprednisolone
Methyltestosterone
Methylthiouracil
Methyprylon
Methysergide
Metoclopramide; except when specified elsewhere in this schedule
Metolazone
Metoprolol
Metribolone
Metrifonate
Metronidazole
Metyrapone
Mexiletine
Mezlocillin
Mianserin
Mibefradil
Mibolerone
Micafungin
Miconazole; except when specified elsewhere in this schedule
Midazolam
Midodrine
Midostaurin
Mifepristone
Migalastat
Miglitol
Miglustat
Milnacipran
Milrinone
Minocycline
Minoxidil; except for dermal use in medicines containing 5% or less
Mirabegron
Mirtazapine
Misoprostol
Mitobronitol
Mitomycin
Mitoxantrone
Mitragyna speciosa
Mitragynine
Mivacurium
Moclobemide
Modafinil
Molgramostim
Molindone
Molracetam
Mometasone; except when specified elsewhere in this schedule
Monobenzone
Monoclonal antibodies; except in pregnancy test kits
Montelukast
Moperone
Morazone
Moricizine
Morphine; except when specified elsewhere in this schedule
Motrazepam
Motretinide
Moxifloxacin
Mumps vaccine; except when administered, in combination with measles and rubella vaccines in a combination product the supply of which the Minister of Health has consented to, by vaccinators, registered pharmacists, or registered intern pharmacists who have successfully completed the Vaccinator Foundation Course (or any equivalent training course approved by the Ministry of Health) and who comply with the immunisation standards of the Ministry of Health (but excluding vaccinators who have completed the Provisional Vaccinator Foundation Course)
Mupirocin
Muraglitazar
Muromonab
Mustine
Mycophenolic acid
Nabilone
Nabumetone
Nadolol
Nadroparin
Nafarelin
Naftidrofuryl
Nalbuphine
Nalidixic acid
Nalmefene
Nalorphine
Naloxegol
Naloxone; except when provided as part of an approved emergency kit for the treatment of opioid overdose
Naltrexone
Nandrolone
Naproxen; except when specified elsewhere in this schedule
Naratriptan
Natalizumab
Natamycin
Nateglinide
Nebacumab
Nebivolol
Nebracetam (and its stereoisomers)
Nedocromil
Nefazodone
Nefiracetam
Nefopam
Nelfinavir
Neomycin
Neostigmine
Nepafenac
Nepidermin
Neratinib
Nerium oleander
Nesiritide
Netilmicin
Netupitant
Nevirapine
Nialamide
Nicardipine
Nicergoline
Nicofuranose
Nicoracetam
Nicorandil
Nicotine; except when specified elsewhere in this schedule; except in preparations for oromucosal or transdermal absorption; for nasal use except when sold from a smoking cessation clinic run under the auspices of a registered medical practitioner; in medicines other than for smoking cessation
Nicotinic acid except nicotinamide; except when specified elsewhere in this schedule
Nicoumalone
Nifedipine
Nifenazone
Nikethamide
Nilotinib
Nilutamide
Nimesulide
Nimetazepam
Nimodipine
Nimorazole
Nintedanib
Niraparib
Niridazole
Nisoldipine
Nitazoxanide
Nitisinone
Nitrazepam
Nitrendipine
Nitric oxide
Nitrofurantoin
Nitrofurazone
Nitrous oxide; when supplied for inhalation
Nitroxoline
Nivolumab
Nizatidine; except when specified elsewhere in this schedule
Nomegestrol
Nomifensine
Noopept (and its stereoisomers)
Noradrenaline
Norandrostenolone
Norbolethone
Norclostebol
Nordazepam
Norelgestromin
Norethandrolone
Norethisterone; except when supplied for oral contraception to women who meet the clinical and eligibility criteria of the Pharmacy Council and the Pharmaceutical Society of New Zealand Incorporated approved training programme on oral contraception, when sold in the manufacturer’s original pack that has received the consent of the Minister or Director-General to their distribution as medicines, containing not more than 6 months’ supply by a registered pharmacist who has successfully completed the approved training programme
Norfloxacin
Norgestrel
Noribogaine
Normethandrone
Nortriptyline
Noxiptyline
Nusinersen
Nux vomica; except in medicines containing 1 milligram or less per litre or per kilogram of strychnine
Nystatin; except when specified elsewhere in this schedule
Obeticholic acid
Obinutuzumab
Ocrelizumab
Ocriplasmin
Octamylamine
Octatropine
Octreotide
Octyl nitrite
Oestradiol; except in medicines containing 10 micrograms or less per litre or per kilogram
Oestriol
Oestrogens
Oestrone; except in medicines containing 1 milligram or less per litre or per kilogram
Ofatumumab
Ofloxacin
Olanzapine
Olaparib
Olaratumab
Oleandomycin
Oleandrin
Olmesartan
Olodaterol
Olopatadine
Olsalazine
Omalizumab
Omberacetam
Ombitasvir
Omeprazole; except when specified elsewhere in this schedule
Ondansetron
Opipramol
Opium
Orciprenaline
Orlistat; except in medicines for weight control containing 120 milligrams or less per dose form
Ornidazole
Ornipressin
Orphenadrine
Orthopterin
Oseltamivir; except when specified elsewhere in this schedule
Osimertinib
Otilonium bromide
Ouabain
Ovandrotone
Oxabolone
Oxacillin
Oxaliplatin
Oxandrolone
Oxaprozin
Oxazepam
Oxazolam
Oxcarbazepine
Oxedrine; except in medicines containing 30 milligrams or less per recommended daily dose
Oxetacaine; except for internal use
Oxiconazole; except when specified elsewhere in this schedule
Oxiracetam (and its stereoisomers)
Oxitropium
Oxolamine
Oxolinic acid
Oxpentifylline
Oxprenolol
Oxybuprocaine; except when used in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board
Oxybutynin
Oxycodone
Oxymesterone
Oxymetholone
Oxyphenbutazone
Oxyphencyclimine
Oxyphenisatin; at all strengths
Oxyphenonium
Oxytetracycline
Oxytocin; except in medicines containing 1 microgram or less per litre or per kilogram
Ozanimod
Paclitaxel
Palbociclib
Palifermin
Paliperidone
Palivizumab
Palonosetron
Pamaquin
Pamidronic acid
Pancreatic enzymes; except in medicines containing 20 000 BP units or less of lipase activity
Pancuronium
Panitumumab
Panobinostat
Pantoprazole; except when specified elsewhere in this schedule
Papaveretum
Papaverine; for injection
Paracetamol; except when specified elsewhere in this schedule
Paraldehyde
Paramethadione
Paramethasone
Parecoxib
Paricalcitol
Paritabprevir
Paromomycin
Paroxetine
Pasireotide
Patent blue V; for injection when used in diagnostic procedures
Patiromer sorbitex calcium
Pazopanib
Pecazine
Pefloxacin
Pegaptanib
Pegaspargase
Pegfilgrastim
Peginterferon
Peginterferon beta-1a
Pegvisomant
Pembrolizumab
Pemetrexed
Pemoline
Pempidine
Penbutolol
Penciclovir; except when specified elsewhere in this schedule
Penicillamine
Pentaerythrityl tetranitrate
Pentagastrin
Pentamethonium
Pentamidine
Pentazocine
Penthienate
Pentolinium
Pentosan polysulfate sodium
Pentostatin
Pentoxifylline
Peramivir
Perampanel
Pergolide
Perhexiline
Pericyazine
Perindopril
Permethrin; except in medicines containing 5% or less
Perphenazine
Pertussis antigen
Pertussis (whooping cough) vaccine
Pertuzumab
Pethidine
Phenacemide
Phenacetin; except when present as an excipient
Phenaglycodol
Phenazone; except for external use
Phenazopyridine
Phenelzine
Pheneticillin
Phenformin
Phenglutarimide
Phenibut
Phenindione
Pheniramine; except when specified elsewhere in this schedule
Phenisatin
Phenobarbital
Phenol; for injection
Phenolphthalein
Phenoperidine
Phenoxybenzamine
Phenoxymethylpenicillin
Phensuximide
Phentermine
Phenthimentonium
Phentolamine
Phenylbutazone
Phenylephrine; except when specified elsewhere in this schedule
Phenylpiracetam
Phenylpropanolamine
Phenyltoloxamine
Phenytoin
Phleum pratense extract
Pholcodine; except when specified elsewhere in this schedule
Phosphodiesterase type 5 inhibitors; except when present as an unmodified, naturally occurring substance; except when specified elsewhere in this schedule
Phthalylsulfathiazole
Physostigmine
Pibrentasvir
Picibanil
Picric acid
Picrotoxin
Pilocarpine; except in medicines containing 0.025% or less
Pimecrolimus
Pimozide
Pinacidil
Pinazepam
Pindolol
Pioglitazone
Pipecuronium
Pipemidic acid
Pipenzolate
Piperacetam
Piperacillin
Piperidine
Piperidolate
Pipobroman
Pipothiazine
Pipradrol
Piracetam
Pirbuterol
Pirenoxine
Pirenzepine
Piretanide
Pirfenidone
Piroxicam; except for external use
Pirprofen
Pitavastatin
Pituitary hormones
Pivampicillin
Pizotifen
Plerixafor
Plicamycin
Plitidepsin
Pneumococcal vaccine; except in oral vaccines for the prophylaxis of bacterial complications of colds
Podophyllotoxin; for internal use; for external use for the treatment of anogenital warts; for other external use in medicines containing more than 1%; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram
Podophyllum emodi; for internal use; for external use for the treatment of anogenital warts; for other external use in medicines containing more than 20% of podophyllin; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram
Podophyllum peltatum; for internal use; for external use for the treatment of anogenital warts; for other external use in medicines containing more than 20% of podophyllin; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram
Polatuzumab vedotin
Polidexide
Poliomyelitis vaccine
Polyacrylamide; in injections or implants for tissue augmentation or cosmetic use
Polyestradiol
Polylactic acid; in injections or implants for tissue augmentation or cosmetic use
Polymyxin
Polysulfated glycosaminoglycans; for injection except in intraocular viscoelastic products
Polythiazide
Pomalidomide
Ponatinib
Poractant alfa
Posaconazole
Potassium bromide
Potassium perchlorate
Practolol
Pradofloxacin
Pralatrexate
Pralidoxime
Pralmorelin
Pramipexole
Pramiracetam
Pramocaine
Prampine
Prasterone
Prasugrel
Pravastatin
Prazepam
Praziquantel
Prazosin
Prednisolone
Prednisone
Pregabalin
Pregnenolone
Prenalterol
Prenylamine
Prilocaine; for injection except when used as a local anaesthetic in practice by a dental therapist or an oral therapist registered with the Dental Council; except when specified elsewhere in this schedule
Primaquine
Primidone
Probenecid
Probucol
Procainamide
Procaine
Procaine penicillin
Procarbazine
Prochlorperazine; except when specified elsewhere in this schedule; except when sold for the treatment of nausea associated with emergency contraception by pharmacists or nurses accredited to sell levonorgestrel for emergency contraception
Procyclidine; except for dermal use in medicines containing 5% or less
Progesterone; except in medicines containing 1 milligram or less per litre or per kilogram
Progestogens
Proglumide
Proguanil
Prolintane
Promazine
Promethazine; except when specified elsewhere in this schedule
Promoxolane
Propafenone
Propamidine; except for ophthalmic use
Propanidid
Propantheline
Propetandrol
Propionibacterium acnes
Propofol
Propranolol; except in medicines containing 1 milligram or less per litre or per kilogram
Propylthiouracil
Propyphenazone
Proquazone
Proscillaridin
Prostaglandins
Protamine
Prothionamide
Prothipendyl
Protirelin
Protoveratrines
Protriptyline
Proxymetacaine; except when used in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board
Prucalopride
Pseudoephedrine
Pulmonaria spp; at all strengths
Pyrazinamide
Pyridinolcarbamate
Pyridostigmine
Pyridoxal; except in medicines containing 200 milligrams or less per recommended daily dose
Pyridoxamine; except in medicines containing 200 milligrams or less per recommended daily dose
Pyridoxine; except in medicines containing 200 milligrams or less per recommended daily dose
Pyrimethamine
Pyrvinium
Quazepam
Quetiapine
Quinagolide
Quinapril
Quinbolone
Quinethazone
Quinidine
Quinine; except in medicines containing 50 milligrams or less per recommended daily dose
Quinisocaine
Quinupristin
Rabeprazole
Rabies vaccine
Racetams; except when specified elsewhere in this schedule
Raloxifene
Raltegravir
Raltitrexed
Ramipril
Ramucirumab
Ranibizumab
Ranitidine; except when specified elsewhere in this schedule
Ranolazine
Rapacuronium
Rasagiline
Rasburicase
Rauwolfia serpentina
Rauwolfia vomitoria
Razoxane
Reboxetine
Recombinant human epidermal growth factor
Recombinant varicella zoster virus glycoprotein E antigen
Regorafenib
Remdesivir
Remestemcel-L
Remifentanil
Remoxipride
Repaglinide
Reserpine
Reslizumab
Retapamulin
Reteplase
Retigabine
Ribavirin
Ribociclib
Ridaforolimus
Rifabutin
Rifampicin
Rifamycin
Rifapentine
Rifaximin
Rilmazafone
Rilpivirine
Riluzole
Rimexolone
Rimiterol
Rimonabant
Riociguat
Ripretinib
Risankizumab
Risedronic acid
Risperidone
Ritodrine
Ritonavir
Rituximab
Rivaroxaban
Rivastigmine
Rizatriptan; except when specified elsewhere in this schedule
Rocuronium
Rofecoxib
Roflumilast
Rolipram (and its stereoisomers)
Rolitetracycline
Rolziracetam
Romidepsin
Romiplostim
Romosozumab
Ropinirole
Ropivacaine
Rosiglitazone
Rosoxacin
Rosuvastatin
Rotavirus vaccine
Rotigotine
Roxibolone
Roxithromycin
Rubella vaccine; except when administered, in combination with measles and mumps vaccines in a combination product the supply of which the Minister of Health has consented to, by vaccinators, registered pharmacists, or registered intern pharmacists who have successfully completed the Vaccinator Foundation Course (or any equivalent training course approved by the Ministry of Health) and who complies with the immunisation standards of the Ministry of Health (but excluding vaccinators who have completed the Provisional Vaccinator Foundation Course)
Ruboxistaurin
Rufinamide
Rupatadine
Ruxolitnib
Sabadilla; except in preparations containing 10 milligrams or less of total alkaloids of schoenocaulon officinale per litre or per kilogram
Sacubitril
Safinamide
Safrole; for internal use except in medicines containing 0.1% or less
Salbutamol
Salcatonin
Salmeterol
Sapropterin
Saquinavir
Sargramostim
Sarilumab
Saxagliptin
Schoenocaulon officinale; except in preparations containing 10 milligrams or less of total alkaloids of schoenocaulon officinale per litre or per kilogram
Scopolia carniolica
Sebelipase alfa
Secbutabarbital
Secobarbital
Secukinumab
Selective androgen receptor modulators
Seletracetam (and its stereoisomers)
Selegiline
Selenium; except when specified elsewhere in this schedule; except for oral use in medicines containing 150 micrograms or less per recommended daily dose
Selexipag
Semaglutide
Serelaxin
Sermorelin
Sertindole
Sertraline
Serum, dried human
Sevelamer
Sevoflurane
Sex hormones and all substances having sex hormone activity
Sialoepoetin
Sibutramine
Silandrone
Sildenafil and its structural analogues; except sildenafil in medicines for oral use containing 100 milligrams or less per dose unit when sold in the manufacturer’s original pack containing not more than 12 solid dosage units for the treatment of erectile dysfunction in males aged 35–70 years by a registered pharmacist who has successfully completed a training programme endorsed by the Pharmaceutical Society of New Zealand Incorporated
Silicones; for injection
Silodosin
Siltuximab
Silver sulfadiazine; except for external use in packs containing 50 grams or less
Simeprevir
Simvastatin
Siponimod
Sirolimus
Sisomicin
Sitagliptin
Sitaxentan
Sodium bromide
Sodium cellulose phosphate; for internal use
Sodium cromoglycate; except for nasal and ophthalmic use
Sodium morrhuate; for injection
Sodium nitroprusside
Sodium phenylbutyrate
Sodium phosphate; in oral laxative preparations
Sodium polystyrene sulphonate
Sodium tetradecyl sulphate; for injection
Sodium zirconium cyclosilicate
Sofosbuvir
Solasadine
Solifenacin
Somatostatin
Somatropin
Sonidegib
Sontoquine
Sorafenib
Sotalol
Sparfloxacin
Sparteine
Spectinomycin
Spiramycin
Spirapril
Spironolactone
Squill
Stanolone
Stanozolol
Staphylococcus aureus vaccine; except in oral vaccines for the prophylaxis of bacterial complications of colds
Stavudine
Stenabolic (SR9009) and other synthetic REV-ERB agonists
Stenbolone
Steroid hormones
Stilboestrol
Stiripentol
Stramonium; except for oral use when specified elsewhere in this schedule; except datura stramonium or datura tatula for smoking or burning
Streptococcus beta-haemolyticus vaccine; except in oral vaccines for the prophylaxis of bacterial complications of colds
Streptodornase
Streptokinase
Streptomycin
Streptozocin
Strontium ranelate
Strophanthins
Strophanthus spp
Strychnos spp; except in medicines containing 1 milligram or less per litre or per kilogram of strychnine
Styramate
Succimer
Sufentanil
Sugammadex
Sulbactam
Sulconazole; except for dermal use
Sulfacetamide; except for ophthalmic use in medicines containing 10% or less
Sulfadiazine; except silver sulfadiazine for external use in pack sizes of 50 grams or less
Sulfadimethoxine
Sulfadimidine
Sulfadoxine
Sulfafurazole
Sulfaguanidine
Sulfamerazine
Sulfamethizole
Sulfamethoxazole
Sulfamethoxydiazine
Sulfamethoxypyridazine
Sulfametrole
Sulfamonomethoxine
Sulfamoxole
Sulfaphenazole
Sulfapyridine
Sulfasalazine
Sulfathiazole
Sulfatroxazole
Sulfinpyrazone
Sulfomyxin
Sulfonmethane
Sulindac
Sultamicillin
Sulthiame
Sumatriptan; except when specified elsewhere in this schedule
Sunifiram
Sunitinib
Suprofen
Suvorexant
Sutilains
Suxamethonium
Suxethonium
T cell receptor antibody
Tacrine
Tacrolimus
Tadalafil and its structural analogues
Tafamidis
Tafenoquine succinate
Tafluprost
Talazoparib
Taliglucerase alfa
Talimogene laherparepvec
Tamoxifen
Tamsulosin
Tanacetum vulgare; except in medicines containing 0.8% or less of oil of tansy
Tapentadol
Tasonermin
Tazarotene
Tazobactam
Teduglutide
Tegafur
Tegaserod
Teicoplanin
Telaprevir
Telbivudine
Telithromycin
Telmisartan
Telotristat ethyl
Temazepam
Temozolomide
Temsirolimus
Tenecteplase
Teniposide
Tenofovir
Tenoxicam
Terazosin
Terbinafine; except when specified elsewhere in this schedule
Terbutaline
Terfenadine
Teriflunomide
Teriparatide
Terlipressin
Terodiline
Teropterin
Tesamorelin
Testolactone
Testosterone; except in medicines containing 1 milligram or less per litre or per kilogram
Tetanus antitoxin
Tetanus toxoid
Tetanus vaccine
Tetrabenazine
Tetracosactrin
Tetracycline
Tetraethylammonium
Tetrahydrocannabinol
Tetrazepam
Tetroxoprim
Thalidomide
Thenyldiamine
Theophylline; except when specified elsewhere in this schedule
Thevetia peruviana
Thevetin
Thiambutosine
Thiazosulfone
Thiethylperazine
Thioacetazone
Thiocarlide
Thioguanine
Thiomesterone
Thiopentone
Thiopropazate
Thioproperazine
Thioridazine
Thiotepa
Thiothixene
Thiouracil
Thiourea; except in medicines containing 0.1% or less
Thymosin beta-4
Thymoxamine
Thyroid
Thyrotrophin
Thyrotrophin-releasing factor
Thyroxine; except in medicines containing 10 micrograms or less per litre or per kilogram
Tiagabine
Tianeptine
Tiaprofenic acid
Tiaramide
Tibolone
Ticagrelor
Ticarcillin
Ticlopidine
Tiemonium
Tienilic acid
Tigecycline
Tigloidine
Tiletamine
Tilidine
Tilmanocept
Tiludronic acid
Timbetasin
Timolol
Tinidazole
Tinzaparin
Tioconazole; except when specified elsewhere in this schedule
Tiotropium
Tipepidine
Tipiracil
Tiprinavir
Tirilazad
Tirofiban
Tivozanib
Tizanidine
Tobramycin
Tocainide
Tocilizumab
Tofacitinib
Tolazamide
Tolazoline
Tolbutamide
Tolcapone
Tolfenamic acid
Tolmetin
Tolonium
Tolpropamine
Tolrestat
Tolterodine
Tolvaptan
Topiramate
Topotecan
Torasemide
Toremifene
Toxoids; for injection
Tramadol
Trametinib dimethyl sulfoxide
Trandolapril
Tranexamic acid
Tranylcypromine
Trastuzumab
Trastuzumab emtansine
Travoprost
Trazodone
Trenbolone
Treosulphan
Treprostinil
Trestolone
Tretamine
Tretinoin
Triacetyloleandomycin
Triamcinolone; except when specified elsewhere in this schedule
Triamterene
Triaziquone
Triazolam
Trichlormethiazide
Trichloroacetic acid; except for external use in medicines containing 12.5% or less for the treatment of warts other than anogenital warts
Trichloroethylene
Trichodesma africana; at all strengths
Triclofos
Tricyclamol
Tridihexethyl
Trientine
Trifluoperazine
Trifluperidol
Triflupromazine
Trifluridine
Trimeprazine; except when specified elsewhere in this schedule
Trimetaphan
Trimethoprim; except in medicines for oral use containing 300 milligrams or less per dose unit when sold in a pack of 3 solid dosage units to a woman aged 16–65 years for the treatment of an uncomplicated urinary tract infection by a registered pharmacist who has successfully completed the New Zealand College of Pharmacists’ training in the treatment of urinary tract infections
Trimipramine
Trimustine
Trinitrophenol
Trioxysalen
Triparanol; at all strengths
Triple antigen vaccine
Triprolidine; except when specified elsewhere in this schedule
Triptorelin
Troglitazone
Trometamol; for injection in medicines containing more than 3%
Tropicamide; except when used in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board
Tropisetron
Trovafloxacin
Troxidone
Tryptophan; except in medicines containing 100 milligrams or less per recommended daily dose; except in parenteral nutrition replacement preparations
Tuberculin
Tuberculosis vaccine
Tubocurarine
Tucatinib
Tulobuterol
Typhoid vaccine
Ulipristal
Umeclidinium bromide
Unifiram
Unoprostone
Upadacitinib
Uracil
Urapidil
Urethane
Urofollitropin
Urokinase
Ursodeoxycholic acid
Ustekinumab
Vaccines; except when specified elsewhere in this schedule
Vaccinia virus vaccine
Valaciclovir
Valdecoxib
Valganciclovir
Valnoctamide
Valproic acid
Valsartan
Vancomycin
Vandetanib
Vardenafil and its structural analogues
Varenicline
Varicella vaccine; except when administered for the prevention of herpes zoster (shingles) to a person 50 years of age or over by a registered pharmacist who has successfully completed the Vaccinator Foundation Course (or any equivalent training course approved by the Ministry of Health) and who complies with the immunisation standards of the Ministry of Health (but excluding a vaccinator who has completed the Provisional Vaccinator Foundation Course)
Vasopressin
Vecuronium
Vedolizumab
Velaglucerase alfa
Velpatasvir
Vemurafenib
Venetoclax
Venlafaxine
Verapamil
Veratrum spp
Vernakalant
Verteporfin
Veruprevir
Vidarabine
Vigabatrin
Vilanterol
Vildagliptin
Viloxazine
Vinblastine
Vincamine
Vincristine
Vindesine
Vinflunine
Vinorelbine
Vinyl ether
Virginiamycin
Vismodegib
Visnadine
Vitamin A; except for internal use in medicines containing 3 milligrams or less of retinol equivalents per recommended daily dose; except in parenteral nutrition replacement preparations; except for external use in medicines containing 1% or less
Vitamin D; except for external use; except for internal use in medicines containing 25 micrograms or less per recommended daily dose; except in parenteral nutrition replacement preparations
Voglibose
Vorapaxar
Voretigene neparvovec
Voriconazole
Vorinostat
Vortioxetine
Voxilaprevir
Warfarin
Xamoterol
Xanthinol nicotinate
Ximelagatran
Xipamide
Yellow fever vaccine
Yohimbine
Zafirlukast
Zalcitabine
Zaleplon
Zanamivir
Zidovudine
Zimeldine
Zinc; except for internal use in medicines containing 25 milligrams or less per recommended daily dose; except for internal use in medicines containing 50 milligrams or less and more than 25 milligrams per recommended daily dose in packs that have received the consent of the Minister or the Director-General to their distribution as general sale medicines, when sold in the manufacturer’s original pack and when labelled with a statement that the product may be dangerous if taken in large amounts or for long periods; except for external use when in medicines containing 5% or less; except in parenteral nutrition replacement preparations
Ziprasidone
Zoledronic acid
Zolmitriptan; except when specified elsewhere in this schedule
Zolpidem
Zonisamide
Zopiclone
Zoster immunoglobulin, human
Zoxazolamine
Zuclopenthixol
Schedule 1, Part 1 item 1090: amended, on 19 May 2022, by regulation 7 of the Medicines Amendment Regulations 2022 (SL 2022/116).
Adrenaline; in medicines containing 1% or less except in medicines for injection containing 0.02% or less
Alclometasone; for dermal use in medicines containing 0.05% or less and in packs containing not more than 30 grams that have received the consent of the Minister or the Director-General to their distribution as restricted medicines, when sold in the manufacturer’s original pack
Aminophylline; for oral use in liquid form in medicines containing 2% or less
Amorolfine; for external use in medicines containing more than 0.25%
Aspirin; in slow-release forms; in enteric coated forms containing more than 300 milligrams per dose form
Azatadine; for oral use in adults and children over 2 years of age
Azelastine; in medicines for ophthalmic use containing 0.05% or less
Brompheniramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of insomnia; for oral use for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units
Buclizine; for oral use
Butoconazole; for vaginal use
Chloramphenicol; for ophthalmic use; except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board
Chlorbutol; except when specified elsewhere in this schedule
Chlorpheniramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of insomnia; for oral use for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units
Ciclopirox; for external use in medicines containing more than 2%; in preparations for application to the nails containing more than 8%
Cimetidine; in medicines for the symptomatic relief of heartburn, dyspepsia, and hyperacidity or to be used on the recommendation of a registered medical practitioner, when sold in the manufacturer’s original pack containing not more than 14 days’ supply
Clemastine; for oral use
Clobetasone; for dermal use in medicines containing 0.05% or less and in packs containing not more than 30 grams that have received the consent of the Minister or the Director-General to their distribution as restricted medicines, when sold in the manufacturer’s original pack
Clotrimazole; for vaginal use
Cyclizine; for oral use other than in medicines used for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 6 dosage units; for oral use in medicines used for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units
Cyproheptadine; for oral use
Dexchlorpheniramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of insomnia; for oral use for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units
Dextromethorphan; in liquid form when in packs containing not more than 600 milligrams and with a recommended daily dose of not more than 120 milligrams; in medicines for the treatment of symptoms of cough and cold in adults and children aged six years and over
Di-iodohydroxy quinoline; for vaginal use
Diclofenac; in solid dose form in medicines containing 25 milligrams or less and more than 12.5 milligrams per dose form in packs containing not more than 30 tablets or capsules
Dimenhydrinate; for oral use in medicines for adults and children over 2 years of age; except when specified elsewhere in this schedule
Dimethindene; for oral use
Diphenhydramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of insomnia; for oral use for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units
Dithranol
Doxylamine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of insomnia; for oral use for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units
Econazole; for vaginal use
Erythrityl tetranitrate
Famciclovir; in divided solid dosage forms for oral use containing 500 milligrams or less for the treatment of recurrent herpes labialis when sold in the manufacturer’s original pack containing up to 3 dosage units
Flavoxate
Fluconazole; for oral use in medicines that have received the consent of the Minister or the Director-General to their distribution as restricted medicines, when sold in the manufacturer’s original pack containing 150 milligrams or less as a single dose for the treatment of vaginal candidiasis
Fluorides; for external use in liquid form in medicines containing 5.5 grams or less and more than 1 gram per litre or per kilogram and when sold in packs approved by the Minister or the Director-General for distribution as restricted medicines; for external use in non-liquid form in medicines containing 5.5 grams or less and more than 1 gram per litre or per kilogram, except in medicines containing 1.5 grams or less and more than 1 gram per litre or per kilogram; except when supplied to a dental professional registered with the Dental Council
Glucagon; except in medicines containing 100 micrograms or less per litre or per kilogram
Glyceryl trinitrate; for oral or sublingual use; for rectal use
Guaifenesin; for oral use in modified release form with a maximum recommended daily dose of not more than 2.4 grams when sold in the manufacturer’s original pack containing more than 10 days’ supply but not more than 30 days’ supply; except for oral use in modified release form with a maximum recommended daily dose of not more than 2.4 grams when sold in the manufacturer’s original pack containing not more than 10 days’ supply; except for oral use in medicines containing 2% or less or 200 milligrams or less per dose form
Haemophilus influenzae vaccine; in oral vaccines for the prophylaxis of bacterial complications of colds
Hydrocortisone and hydrocortisone acetate but no other esters of hydrocortisone; for dermal use in medicines containing 1% or less but more than 0.5% by weight of hydrocortisone base with no other active ingredient except an antifungal and in a quantity of 30 grams or less or 30 millilitres or less per container; for dermal use in medicines containing 1% or less but more than 0.5% by weight of hydrocortisone base with no other active ingredient except 5% or less by weight of aciclovir and in a quantity of 2 grams or less or 2 millilitres or less per container in adults and children 12 years of age and older; in rectal medicines containing 1% or less but more than 0.5% by weight of hydrocortisone base and in combination with a local anaesthetic and in a quantity of 35 grams or less per container or up to 12 suppositories per pack
Hyoscine butylbromide; for oral use in medicines containing not more than 20 milligrams per dose form and in packs containing not more than 10 tablets or capsules for the relief of muscle spasm of the gastrointestinal tract
Ibuprofen; for oral use in tablets or capsules containing up to 400 milligrams per dose form and in packs containing not more than 50 dose units and that have received the consent of the Minister or the Director-General to their distribution as restricted medicines, when sold in the manufacturer’s original pack labelled for use by adults or children over 12 years of age
Inositol nicotinate
Isoconazole; for vaginal use
Ketoprofen; in solid dose form containing 25 milligrams or less per dose form in packs of not more than 30 capsules or tablets
Lansoprazole; in divided solid dosage forms for oral use containing 15 milligrams or less with a maximum daily dose of 15 milligrams for the short-term symptomatic relief of gastric reflux-like symptoms in sufferers aged 18 years and over for the relief of heartburn when sold in the manufacturer’s original pack containing not more than 14 dosage units
Levonorgestrel; in medicines for use as emergency post-coital contraception when in packs containing not more than 1.5 milligrams
Macrogols; in oral preparations for bowel cleansing prior to diagnostic, medical, or surgical procedures
Malathion; except for external use in medicines containing 2% or less
Mannityl hexanitrate
Meclozine; in a pack size of up to 10 dosage units for the treatment of insomnia
Mepyramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of insomnia; for oral use for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units
Methdilazine; for oral use
Metoclopramide; when compounded with paracetamol in packs of not more than 10 tablets or capsules for the treatment of nausea associated with migraine
Miconazole; for the treatment of oral candidiasis; for vaginal use
Nicotinic acid except nicotinamide; in medicines containing 250 milligrams or less but more than 100 milligrams per dose form; except in medicines containing 100 milligrams or less per dose form
Nicotinyl alcohol; except in medicines containing 100 milligrams or less per dose form
Nystatin; for the treatment of oral candidiasis; for vaginal use
Orlistat; in medicines for weight control containing 120 milligrams or less per dose form
Oseltamivir; in solid dosage forms for oral use containing 75 milligrams in a pack size of up to 10 dosage units for the treatment or prophylaxis of influenza in adults and children aged 13 years and older who have been exposed to the influenza virus
Oxiconazole; for vaginal use
Paracetamol; in modified-release forms containing 665 milligrams or less
Pheniramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of insomnia; for oral use for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units
Pneumococcal vaccine; in oral vaccines for the prophylaxis of bacterial complications of colds
Podophyllotoxin; for external use for the treatment of warts other than anogenital warts in medicines containing 1% or less and more than 0.5%; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram
Podophyllum emodi; for external use for the treatment of warts other than anogenital warts in medicines containing 20% or less and more than 10% of podophyllin; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram
Podophyllum peltatum; for external use for the treatment of warts other than anogenital warts in medicines containing 20% or less and more than 10% of podophyllin; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram
Prochlorperazine; in packs containing not more than 10 tablets or capsules for the treatment of nausea associated with migraine
Promethazine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of insomnia; for oral use for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units
Rizatriptan; for oral use in medicines for the acute relief of migraine attacks with or without aura in patients who have a stable, well-established pattern of symptoms, when in wafers containing 5 milligrams or less per wafer and when sold in a pack containing not more than 2 wafers approved by the Minister or the Director-General for distribution as a restricted medicine
Salicylic acid; except in medicines for dermal use containing 40% or less
Santonin
Sodium phosphate; in oral preparations for bowel cleansing prior to diagnostic, medical, or surgical procedures
Sodium picosulphate; in oral preparations for bowel cleansing prior to diagnostic, medical, or surgical procedures
Staphyloccocus aureus vaccine; in oral vaccines for the prophylaxis of bacterial complications of colds
Stramonium; for oral use in liquid form; in solid dose form in medicines containing more than 0.3 milligrams per dose or more than 1.2 milligrams per recommended daily dose
Streptococcus beta-haemolyticus vaccine; in oral vaccines for the prophylaxis of bacterial complications of colds
Sulfacetamide; for ophthalmic use in medicines containing 10% or less
Sumatriptan; for oral use in medicines for the acute relief of migraine attacks with or without aura in patients who have a stable, well-established pattern of symptoms when in tablets containing 50 milligrams or less per tablet and when sold in a pack containing not more than 2 tablets that has received the consent of the Minister or the Director-General to its sale as a restricted medicine
Theophylline; in liquid form for oral use in medicines containing 2% or less
Tioconazole; for vaginal use
Triamcinolone; for buccal use in medicines containing 0.1% or less of triamcinolone acetonide and in pack sizes of 5 grams or less
Trimeprazine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of insomnia; for oral use for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units
Triprolidine; for oral use in medicines for adults and children over 2 years of age; except when specified elsewhere in this schedule
Zolmitriptan; in a pre-filled nasal spray device containing not more than 5 milligrams of zolmitriptan, for the acute relief of migraine attacks with or without aura in patients who have a stable, well-established pattern of symptoms and when sold in a pack of not more than 2 devices approved by the Minister or the Director-General for distribution as a restricted medicine
8-hydroxyquinoline and its non-halogenated derivatives; in medicines containing more than 1% of such substances; except for hydroxyquinoline sulphate for external use
Acetic acid and preparations containing more than 80% of acetic acid (CH3COOH); excluding its salts and derivatives
Acetylcysteine; for oral use in medicines containing more than 1 gram per recommended daily dose
Aciclovir; for external use for the treatment of herpes labialis except in medicines containing 5% or less and in tubes containing 10 grams or less
Aconitum spp; for oral use in packs containing 0.2 milligrams or less and more than 0.02 milligrams of total alkaloids; for dermal use in concentrations of 0.02% or less and in packs containing 0.2 milligrams or less and more than 0.02 milligrams of total alkaloids
Aloes; for internal use; except when obtained solely from the mucilaginous gel of the leaf
Aloin
Aloxiprin
Amethocaine; for external use in medicines containing 10% or less and more than 2%; except in medicines for external use containing 2% or less
Amorolfine; in preparations for topical use; except in preparations for the treatment of tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board
Antazoline; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board
Atropa belladonna; for external use in medicines containing 0.03% or less of the alkaloids of belladonna; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of the alkaloids of belladonna or in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of the alkaloids of belladonna
Atropine; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose or in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose; in medicines containing atropine sulphate for the treatment of organophosphorus poisoning either in packs of not more than 20 dose units containing 0.6 milligrams or less per dose unit or in injections in packs of not more than 5 vials containing 0.6 milligrams per millilitre; except when sold as an antidote in a device designed for self-injection from outlets licensed to sell organophosphorus poisons; except in medicines containing 300 micrograms or less per litre or per kilogram
Azelaic acid; for dermal use
Azelastine; in preparations for nasal use containing 0.15% azelastine hydrochloride or less; in topical eye preparations containing 0.05% or less
Beclomethasone; for the treatment or prophylaxis of allergic rhinitis in adults and children over 12 years of age in aqueous nasal sprays delivering up to 50 micrograms per actuation when the maximum recommended daily dose is no greater than 400 micrograms (200 micrograms per nostril) in a pack containing 200 actuations or less
Benzocaine; in preparations for topical use, other than eye drops, containing 10% or less of total anaesthetic substances except in dermal preparations containing 2% or less of total anaesthetic substances; in divided preparations containing 200 milligrams or less of total anaesthetic substances per dosage unit except in lozenges containing 30 milligrams or less of total anaesthetic substances per dosage unit
Benzoyl peroxide; for external use in medicines containing more than 5% and not more than 10%; except for medicines for external use containing 5% or less
Benzydamine; for external use except for oromucosal or topical use
Bephenium
Bifonazole; except when specified elsewhere in this schedule; except for dermal use in medicines for tinea pedis only or in shampoos containing 1% or less or when sold in practice by a podiatrist registered with the Podiatrists Board
Bilastine; in divided solid dosage forms for oral use containing 20 milligrams or less for the treatment of the symptoms of allergic rhinoconjunctivitis (seasonal and perennial)
Bisacodyl
Bromhexine
Brompheniramine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing brompheniramine or when at least 1 of the other active ingredients is a sympathomimetic decongestant
Budesonide; for the treatment or prophylaxis of allergic rhinitis in adults and children over 12 years of age in aqueous nasal sprays delivering up to 64 micrograms per actuation and when the maximum recommended daily dose is no greater than 400 micrograms (200 micrograms per nostril)
Carbetapentane; except in medicines containing 0.5% or less
Carbocisteine
Cetirizine; for oral use except in divided solid dosage forms for oral use containing 10 milligrams or less of cetirizine hydrochloride per dose form for the treatment of seasonal allergic rhinitis when sold in the manufacturer’s original pack containing not more than 5 days’ supply
Chlophedianol
Chlorbutol; in medicines containing 5% or less and more than 0.5%; except in medicines containing 0.5% or less
Chloroform; in medicines other than for anaesthesia containing more than 0.5%; except in medicines containing 0.5% or less
Chlorpheniramine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing chlorpheniramine or when at least 1 of the other active ingredients is a sympathomimetic decongestant
Ciclopirox; for external use in medicines containing 2% or less except when for the treatment of tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board; in preparations for application to the nails containing 8% or less
Cinchocaine; for external use in medicines containing 0.5% or less
Cinnamedrine
Clotrimazole; for external use except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board
Cocaine; in medicines for oral use, containing not more than 0.1% of cocaine, when combined with 1 or more active ingredients in such a way that the substance cannot be recovered by readily applicable means or in a yield that would constitute a risk to health, and when sold in a pack approved by the Minister or the Director-General for distribution as a pharmacy-only medicine
Colocynth
Creosote; except in medicines containing 10% or less
Cresols; except in medicines containing 3% or less
Datura spp; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids; in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids
Delphinium staphisagria; except in medicines containing 0.2% or less
Desloratadine; for oral use
Dexchlorpheniramine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing dexchlorpheniramine or when at least 1 of the other active ingredients is a sympathomimetic decongestant
Dextromethorphan; in liquid form containing more than 0.25% or in solid dose form containing more than 15 milligrams per dose form when in packs containing not more than 600 milligrams and with a recommended daily dose of not more than 120 milligrams; in medicines for the treatment of the symptoms of cough and cold in children aged 6–12 years; except in liquid form containing 0.25% or less in solid dose form containing 15 milligrams or less per dose form when in packs containing not more than 600 milligrams and with a recommended daily dose of not more than 120 milligrams
Dibrompropamidine; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board
Diclofenac; in solid dose form in medicines containing 12.5 milligrams or less per dose form in packs containing not more than 30 tablets or capsules and with a recommended daily dose of not more than 75 milligrams
Diphenoxylate; in liquid form containing in each millilitre not more than 0.5 milligrams of diphenoxylate calculated as base and not less than 5 micrograms of atropine sulphate; in solid dose form containing not more than 2.5 milligrams of diphenoxylate calculated as base and not less than 5 micrograms of atropine sulphate
Dimenhydrinate; for oral use in a sealed container of not more than 10 tablets or capsules for the prevention or treatment of motion sickness in adults or children over 2 years of age except when sold at a transport terminal or aboard a ship or an aircraft
Diphenhydramine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing diphenhydramine or when at least 1 of the other active ingredients is a sympathomimetic decongestant; for oral use in a sealed container of not more than 10 tablets or capsules for the prevention or treatment of motion sickness in adults and children over 2 years of age except when sold at a transport terminal or aboard a ship or an aircraft
Doxylamine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing doxylamine or when at least 1 of the other active ingredients is a sympathomimetic decongestant
Duboisia leichhardtii; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids; in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids
Duboisia myoporides; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids; in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids
Econazole; for dermal use except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board
Esomeprazole; in oral preparations containing 20 milligrams or less per dosage unit for the relief of heartburn and other symptoms of gastro-oesophageal reflux disease, in packs containing not more than 14 days’ supply
Etafedrine
Ether; in medicines containing more than 10%; except in medicines containing 10% or less
Etofenamate; for external use
Famotidine; for the symptomatic relief of heartburn, dyspepsia, and hyperacidity or to be used on the recommendation of a registered medical practitioner, when sold in the manufacturer’s original pack containing not more than 14 days’ supply
Felbinac; for external use
Fexofenadine; for oral use except for the treatment of seasonal allergic rhinitis in adults and children 12 years of age and over when in capsules containing 60 milligrams or less of fexofenadine hydrochloride or in tablets containing 120 milligrams or less of fexofenadine hydrochloride with a maximum daily dose of 120 milligrams when sold in the manufacturer’s original pack containing 20 dosage units or less and not more than 10 days’ supply; for the treatment of seasonal allergic rhinitis in adults and children 12 years of age and over when in tablets containing 180 milligrams or less of fexofenadine hydrochloride with a maximum daily dose of 180 milligrams when sold in the manufacturer’s original pack containing 5 dosage units or less and not more than 5 days’ supply
Fluorides; for internal use in medicines containing 0.5 milligrams or less per dose unit; except in parenteral nutrition replacement preparations; for external use in liquid form in medicines containing 1 gram or less per litre or per kilogram and when sold in packs approved by the Minister or the Director-General for distribution as pharmacy-only medicines except in medicines containing 220 milligrams or less per litre or per kilogram and in packs containing not more than 120 milligrams of total fluoride; except when supplied to any dental professional registered with the Dental Council; except in medicines containing 15 milligrams or less per litre or per kilogram
Flurbiprofen; in locally acting oromucosal preparations containing 10 milligrams or less per dosage unit
Fluticasone; for the treatment or prophylaxis of allergic rhinitis in adults and children over 12 years of age when in aqueous nasal sprays delivering up to 50 micrograms per actuation with a maximum recommended daily dose of 200 micrograms (as a single dose)
Folic acid; for oral use in medicines containing more than 500 micrograms per recommended daily dose; except for oral use in medicines containing 500 micrograms or less per recommended daily dose; except in parenteral nutrition replacement preparations
Folinic acid; for oral use in medicines containing more than 500 micrograms per recommended daily dose; except for oral use in medicines containing 500 micrograms or less per recommended daily dose
Formaldehyde; except in medicines containing 5% or less
Gelsemium sempervirens; except in medicines containing 1 milligram or less per litre or per kilogram
Glutaraldehyde
Hexachlorophane; in medicines containing 3% or less but more than 0.75%; except in medicines containing 0.75% or less
Hydrocortisone and hydrocortisone acetate but no other esters of hydrocortisone; for dermal use in medicines containing 0.5% or less by weight of hydrocortisone base with no other active ingredient except an antifungal and in a quantity of 30 grams or less or 30 millilitres or less per container; in rectal medicines containing 0.5% or less by weight of hydrocortisone base and in combination with a local anaesthetic and in a quantity of 35 grams or less per container or 12 suppositories or fewer per pack
Hydrocyanic acid; for oral use in packs containing 5 milligrams or less and more than 0.5 milligrams; except in medicines containing 1 microgram or less per litre or per kilogram; except for oral use in packs containing 0.5 milligrams or less
Hydroquinone; for external use in medicines containing 2% or less except in hair preparations containing 1% or less
Hyoscine; for transdermal use in medicines containing 2 milligrams or less of total solanaceous alkaloids per dose unit; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids; in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids
Hyoscyamine; for external use in medicines containing 0.03% or less of total solanaceous alkaloids; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids; in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids
Hyoscyamus niger; for oral use in liquid form in medicines containing 0.03% or less (300 micrograms or less of total solanaceous alkaloids per litre or per kilogram) and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids or in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose except in packs containing 30 micrograms or less of total solanaceous alkaloids
Ibuprofen; for oral use in liquid form with a recommended daily dose of not more than 1.2 grams for the relief of pain and reduction of fever or inflammation when sold in the manufacturer’s original pack containing not more than 8 grams; for oral use in solid dose form containing not more than 200 milligrams per dose form and with a recommended daily dose of not more than 1.2 grams when sold in the manufacturer’s original pack containing not more than 100 dose units; except in divided solid dosage forms for oral use containing 200 milligrams or less per dose form with a recommended daily dose of not more than 1.2 grams and when sold in the manufacturer’s original pack containing not more than 25 dose units; except for external use
Indanazoline
Indomethacin; for external use in medicines containing 1% or less; except in medicines containing 1 milligram or less per litre or per kilogram
Iodine; except for external use in medicines containing 2.5% or less; for internal use in medicines containing less than 300 micrograms per recommended daily dose
Ipecacuanha; in medicines containing 0.2% or less of emetine and 40 micrograms or more of ipecacuanha alkaloids per recommended dose for the treatment of the symptoms of cough and cold in children aged 6–12 years; except in medicines containing less than 40 micrograms of ipecacuanha alkaloids per recommended dose for the treatment of the symptoms of cough and cold in children aged 6–12 years
Ipomoea spp; except ipomoea batatas
Ipratropium; for nasal use
Iron; for oral use either in medicines containing more than 24 milligrams per recommended daily dose or in medicines containing more than 5 milligrams per dose unit and more than 750 milligrams of iron per pack; except in parenteral nutrition replacement preparations; except for oral use in medicines containing 24 milligrams or less per recommended daily dose in medicines containing not more than 5 milligrams per dose unit; except for oral use in medicines containing 24 milligrams or less per recommended daily dose in medicines containing more than 5 milligrams per dose unit in packs containing not more than 750 milligrams of iron
Isoconazole; for dermal use except when sold in practice by a podiatrist registered with the Podiatrists Board
Isopropamide; for dermal use in preparations containing 2% or less
Jalap resin
Ketoconazole; for dermal use except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board; except in medicines for treatment of the scalp containing 1% or less
Ketotifen; for ophthalmic use in medicines containing 0.025% or less except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board
Leucovorin; in medicines containing more than 500 micrograms per recommended daily dose
Levocabastine; for nasal use; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board
Levocetirizine; for oral use
Lignocaine; for urethral use; for external use in medicines containing 10% or less and more than 2%
Lindane; for external use in medicines containing 2% or less
Lithium; for dermal use in medicines containing 1% or less but more than 0.01%; except for dermal use in medicines containing 0.01% or less
Lobelia inflata; except in medicines for smoking or burning
Lobeline; except when in medicines for smoking or burning
Lodoxamide; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board
Loperamide; in packs containing not more than 20 tablets or capsules; except in divided solid dosage forms for oral use containing 2 milligrams or less of loperamide per dosage form when sold in a pack containing not more than 8 dosage forms approved by the Minister or the Director-General for distribution as a general sales medicine for the symptomatic treatment of acute non-specific diarrhoea
Loratadine; for oral use; except in divided solid dosage forms for oral use containing 10 milligrams or less per dose form for the treatment of seasonal allergic rhinitis when sold in the manufacturer’s original pack containing not more than 10 days’ supply
Macrogols; in preparations for oral use as a liquid concentrate for laxative use
Mebendazole
Meclozine; in a sealed container of not more than 12 tablets or capsules for the prevention or treatment of travel sickness except when sold at a transport terminal or aboard a ship or aircraft
Mefenamic acid; in solid dose form in packs containing not more than 30 tablets or capsules for the treatment of dysmenorrhoea
Mepyramine; for dermal use; except for external use in medicines containing 2% or less in packs not exceeding 25 grams
Mercuric oxide; for ophthalmic use
Mercurochrome; in preparations for external use containing 2% or less
Mercury; for external use in medicines containing 0.5% or less; except in medicines containing 1 milligram or less per litre or per kilogram
Methoxamine; for external use in medicines containing more than 1%; except for external use in medicines containing 1% or less
Methoxyphenamine
Methylephedrine
Miconazole; for external use except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board
Minoxidil; for dermal use in medicines containing 5% or less
Mometasone; for the treatment or prophylaxis of allergic rhinitis in adults and children over 12 years of age in aqueous nasal sprays delivering up to 50 micrograms per actuation when the maximum recommended daily dose is no greater than 200 micrograms (as a single dose) in a pack containing 200 actuations or less
Morphine; in medicines for oral use containing not more than 0.2% of morphine, when combined with 1 or more active ingredients in such a way that the substance cannot be recovered by readily applicable means or in a yield that would constitute a risk to health, when sold in a pack approved by the Minister or the Director-General for distribution as a pharmacy-only medicine
Naphazoline; except for ophthalmic use when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board
Naproxen; in solid dose form containing 250 milligrams or less per dose form in packs of not more than 30 tablets or capsules
Niclosamide
Nicotine; for inhalation except when sold from a smoking cessation clinic run under the auspices of a registered medical practitioner, nurse, pharmacist, or psychologist
Nizatidine; in medicines for the symptomatic relief of heartburn, dyspepsia, and hyperacidity or to be used on the recommendation of a registered medical practitioner, when sold in the manufacturer’s original pack containing not more than 14 days’ supply
Noscapine
Nystatin; for dermal use except when sold in practice by a podiatrist registered with the Podiatrists Board; except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board
Omeprazole; in divided solid dosage forms for oral use containing 20 milligrams or less with a maximum daily dose of 20 milligrams for the short-term symptomatic relief of gastric reflux-like symptoms in sufferers aged 18 years and over when sold in the manufacturer’s original pack containing not more than 28 dosage units
Opium; in medicines for oral use containing not more than 0.2% of morphine, when combined with 1 or more active ingredients in such a way that the substance cannot be recovered by readily applicable means, or in a yield that would constitute a risk to health, when sold in a pack approved by the Minister or the Director-General for distribution as a pharmacy-only medicine
Oxetacaine; for internal use
Oxiconazole; for dermal use except in medicines for tinea pedis only
Oxymetazoline; except for nasal use when sold at an airport; except for ophthalmic use when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board; except for nasal use in medicines containing 0.05% or less when sold in the manufacturer’s original pack with a pack size of 20 millilitres or less
Pantoprazole; in divided solid dosage forms for oral use containing 20 milligrams or less with a maximum daily dose of 20 milligrams for the short-term symptomatic relief of gastric reflux-like symptoms in sufferers aged 18 years and over when sold in the manufacturer’s original pack containing not more than 28 dosage units
Papaverine; except for injection
Paracetamol; in liquid form; in suppositories; in tablets or capsules containing 500 milligrams or less and in packs containing more than 10 grams and not more than 50 grams; in powder form containing not more than 1 gram per sachet and more than 10 grams per pack; except in tablets or capsules containing 500 milligrams or less and in packs containing not more than 10 grams; except in powder form in sachets containing 1 gram or less and in packs of not more than 10 grams
Paraformaldehyde; except in medicines containing 5% or less
Penciclovir; for external use for the treatment of herpes labialis; except in medicines for external use containing 1% or less in a pack containing 10 grams or less for the treatment of herpes labialis
Phedrazine
Phenazone; for external use
Pheniramine; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing pheniramine or when at least 1 of the other active ingredients is a sympathomimetic decongestant
Phenol; except in medicines other than for injection containing 3% or less
Phenylephrine; for nasal use in medicines containing more than 1%; for ophthalmic use in medicines containing 5% or less and more than 1%; for oral use in medicines containing more than 50 milligrams per recommended daily dose or in packs containing more than 250 milligrams of phenylephrine per pack; in medicines for the treatment of the symptoms of cough and cold in children aged 6–12 years; except for nasal or ophthalmic use in medicines containing 1% or less; except for oral use in medicines containing 50 milligrams or less per recommended daily dose and in packs containing 250 milligrams or less of phenylephrine per pack
Pholcodine; in medicines for oral use containing not more than 15 milligrams of pholcodine per solid dosage unit or per dose of liquid with a maximum daily dose not exceeding 100 milligrams of pholcodine, when combined with 1 or more active ingredients in such a way that the substance cannot be recovered by readily applicable means, or in a yield that would constitute a risk to health, when sold in a pack approved by the Minister or the Director-General for distribution as a pharmacy-only medicine
Piperazine
Podophyllotoxin; for external use for the treatment of warts other than anogenital warts in medicines containing 0.5% or less; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram
Podophyllum emodi; for external use for the treatment of warts other than anogenital warts in medicines containing 10% or less of podophyllin; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram
Podophyllum peltatum; for external use for the treatment of warts other than anogenital warts in medicines containing 10% or less of podophyllin; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram
Potassium; for internal use: in slow-release or enteric coated forms; except for internal use: in medicines containing 100 milligrams or less per recommended dose; in medicines containing more than 100 milligrams per recommended dose except in medicines for oral rehydration therapy, parenteral nutrition replacement, or dialysis; except in glucosamine sulphate complexed products containing 600 milligrams or less of potassium chloride per recommended dose; except for external use
Potassium chlorate; except in medicines containing 10% or less
Prilocaine; for dermal use in medicines containing 10% or less of local anaesthetic substances
Procyclidine; for dermal use in medicines containing 5% or less
Promethazine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing promethazine or when at least 1 of the other active ingredients is a sympathomimetic decongestant; for oral use in a sealed container of not more than 10 tablets or capsules for the prevention or treatment of motion sickness in adults and children over 2 years of age except when sold at a transport terminal or aboard a ship or aircraft
Propamidine; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board
Pyrantel
Pyrethrins; except in medicines containing 10% or less
Pyrithione zinc; except in medicines for treatment of the scalp containing 2% or less
Ranitidine; in medicines for the symptomatic relief of heartburn, dyspepsia, and hyperacidity or to be used on the recommendation of a registered medical practitioner when sold in the manufacturer’s original pack containing not more than 14 days’ supply; except in medicines containing 300 milligrams or less per dose unit when sold in the manufacturer’s original pack containing not more than 7 days’ supply
Salicylamide
Selenium; for oral use in medicines containing 300 micrograms or less and more than 150 micrograms per recommended daily dose; for external use except in medicines containing 3.5% or less of selenium sulphide
Sennosides
Silver; except in oral solutions containing 0.3% or less or other medicines containing 1% or less
Silver sulfadiazine; for external use in pack sizes of 50 grams or less
Sodium cromoglycate; for nasal use; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board
Sodium nitrite; except for use as an excipient
Sodium picosulphate; in oral laxative preparations
Squill; except in medicines containing 1% or less
Stramonium; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids; in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids
Sulconazole; for dermal use
Sulfadiazine, silver; for external use in pack sizes of 50 grams or less
Terbinafine; for dermal use except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board
Tetrachloroethylene
Tetrahydrozoline; except for ophthalmic use when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board
Thiabendazole
Tioconazole; for dermal use except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board
Tramazoline
Triamcinolone; for the treatment or prophylaxis of allergic rhinitis in adults and children over 12 years of age and when in aqueous nasal sprays delivering up to 55 micrograms per actuation when the maximum recommended daily dose is no greater than 220 micrograms and the medicine has received the consent of the Minister or the Director-General to its distribution as a pharmacy-only medicine
Trimeprazine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing trimeprazine or when at least 1 of the other therapeutically active ingredients is a sympathomimetic decongestant
Triprolidine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing triprolidine or when at least 1 of the other active ingredients is a sympathomimetic decongestant
Tuaminoheptane
Tymazoline
Xylenols; except in medicines containing 3% or less
Xylometazoline; except for nasal use when sold at an airport; except for ophthalmic use when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board
Zinc chloride; for dermal use in medicines containing more than 5%